Editorial Feed
News
Latest news and signals across private equity, venture capital, M&A, and more.
Filters
200 shown of 200
Never miss breaking news
Set up alerts to get notified about new news that match your interests.
Generali Real Estate Nears Full Deployment of €1B Debt Fund
Generali Real Estate is close to investing its entire €1 billion European debt fund, GREDIF II, showcasing strong capital deployment and market confidence.
Culver City Mixed-Use Project Secures $132.7M Construction Loan
Lincoln Property Company and McCourt Partners secure $132.7M construction loan from Bank OZK for Culver City mixed-use project.
Granarolo Secures €450M Sustainability-Linked Debt
Granarolo Group secures €450M sustainability-linked financing, coordinated by Intesa Sanpaolo, integrating ESG targets with financial incentives.
ACORE Capital Refinances Prime SoHo Mixed-Use Asset
ACORE Capital provides new financing for a prime SoHo mixed-use property, securing capital for a 390,000 sq ft asset with strong retail and office tenants.
Castlelake Launches $1.1B CRE CLO Debut
Castlelake debuts in the CRE CLO market, raising $1.1 billion with a diversified portfolio of bridge loans and investment-grade rated notes.
SOAR AI Secures $1B Facility for AI Infrastructure Growth
SOAR AI secures up to $1 billion equity facility to expand its AI infrastructure, backed by a $1.17B customer agreement.
BGO Expands Victoria Multifamily Footprint
BGO strengthens its Victoria multifamily portfolio with a $102M acquisition of The James, following a prior $160M investment.
Foresight Bolsters Finnish Grid with Major BESS Acquisition
Foresight Energy Infrastructure Partners II acquires Finland's largest BESS project, Nivala, from FRV to boost grid stability.
North.cloud Secures $60M to Automate Cloud Spend
North.cloud raises $60M Series B led by PeakSpan Capital to enhance AI and cloud spend optimization. Investors include Litquidity Ventures, Companyon Ventures, and others.
Chubby Group Secures $50M to Fuel Restaurant Expansion
Chubby Group raises $50M Series A led by Prysm Capital at $500M valuation, plans $100M acquisition of GEN Korean BBQ.
Labelbox Fuels AI Agent Development with $100M+ Raise
Labelbox secures over $100M in Series E funding, including a credit facility, to advance AI agent development with key investors.
Mueon Secures $65M for Modular AI Compute
Mueon secures $65M Series A led by Maverick Silicon, with Intel Capital and others, for its modular AI compute platform.
Fission Secures $10M to Boost Tokenized Fund Liquidity
Fission raises $10M Series A led by Pantera Capital to build liquidity infrastructure for tokenized investment funds.
EQT Bolsters Real Estate Arm with Stockbridge Acquisition
EQT acquires US real estate manager Stockbridge for up to $550M, expanding its global platform and diversifying its real estate offerings.
Activist Investor Urges Big Yellow Sale
Activist investor Ancora Holdings Group is pushing for the sale of Big Yellow Group, citing strong buyer interest and a significant undervaluation.
EMK Capital Extends VDK Growth with New Continuation Fund
EMK Capital secures new capital for VDK's European expansion via a continuation vehicle co-led by Coller EQT.
GTCR Fuels Sophos with $200M Debt Facility
GTCR co-leads $200M second lien loan for Thoma Bravo's Sophos, showcasing its new Capital Solutions strategy.
Neurodivergent Support App Expands to DACH Market
Austrian startup bloomnow launches its neurodivergent child support app across Austria, Germany, and Switzerland, tapping into the growing digital health market.
Anduril Valuation Soars to $90B Amid Defense Tech Boom
Defense tech startup Anduril achieves a $90 billion valuation, fueled by strong revenue growth and investor confidence in advanced military solutions.
Anduril's Defense Valuation Soars to $90B
Defense tech innovator Anduril achieves a $90 billion valuation, fueled by strong revenue growth and investor confidence in its advanced autonomous systems.
Altay Therapeutics Secures $37M for Oral FSHD Drug
Altay Therapeutics raises $37M Series A led by Sound Bioventures and HealthCap to advance oral FSHD drug DX5057 into clinical trials.
Never Miss a Deal
Get weekly investment intelligence. Free forever.